Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
Sermsiri Sangroongruangsri,1 Usa Chaikledkaew,1,2 Prut Hanusaha,3 Tanapat Ratanapakorn,4 Paisan Ruamviboonsuk5 1Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand; 2Mahidol University Health Technology Assessment (MUHTA) Gr...
Saved in:
Main Authors: | Sangroongruangsri S, Chaikledkaew U, Hanusaha P, Ratanapakorn T, Ruamviboonsuk P |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/67b022bcc6ad4fccbb614ba25aaf8fef |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
by: Takahashi K, et al.
Published: (2018) -
Survey of Intravitreal Injection Techniques Among Retina Specialists in Mexico
by: Henaine-Berra A, et al.
Published: (2020) -
Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
by: Ratanasukon M, et al.
Published: (2018) -
Choroidal excavation with polypoidal choroidal vasculopathy: a case report
by: Kobayashi W, et al.
Published: (2012) -
Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
by: Matsuo Y, et al.
Published: (2021)